Controversy as pharma execs predict profits from COVID-19 vaccines
Silver bullets fly in Asia
Getting Out of Cash Is Key to Wealth and Inflation Protection, Pompliano Says
USD/CHF Continues Slide Below 0.94 As SNB Defends Franc Interventions
Are Silver bulls outperforming Gold?
Four More Months...
US Close – Netflix disappoints, US Retail sales impresses, EU Council meeting on tap, Oil softens, Gold tumbles
CFTC Committee to Hold Remote Meeting on DLT and Digital Currencies
America's Collective "Kick The Can Down The Road" Mindset
Merck CEO Expresses Concern About Rapid Covid-19 Vaccine Development
Merck & Co’s CEO has doubts over fast COVID-19 vaccine development
GSK-partnered Medicago starts trials of plant-based COVID-19 vaccine
U.S. Covid-19 vaccine program to start manufacturing by late summer
Futures Slide, Follow China Lower After Beijing-Owned Funds Start Selling Stocks
Coronavirus pharma news roundup – 10/07/20
US snaps up first supplies of Regeneron’s COVID-19 antibody
Covid-19 roundup: EU backs Osivax's pursuit of a universal vaccine to fight Covid-19
GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada
Major currencies move back into range trading mode
Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials
Monthly Market Monitor – July 2020
Emergent Bio Signs Major Manufacturing Deal For J&J's Covid-19 Vaccine
GSK and Sanofi close in on £500m COVID-19 vaccine deal with UK – report
Prices Are Going To Rise... And Fast!
Coronavirus pharma news roundup – 03/07/20
NIH Director Collins optimistic on COVID-19 vaccine by year end
US government buys most of world’s supply of COVID-19 drug remdesivir
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
The Real Pandemic Was A Nursing Home Problem
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient